Higher suicide deaths are seen among cancer patients who do not undergo recommended surgery, according to a research letter published online Sept. 3 in JAMA Network Open.
Sep 5, 2024
0
1
Rates of prostate cancer across Europe since 1980 are "indicative of overdiagnosis," say researchers in a study published by The BMJ.
Sep 4, 2024
0
0
A Korean study published recently suggests that people with type 2 diabetes who are prescribed a particular class of drug might be at a significantly lower risk of dementia.
Sep 4, 2024
0
2
A study led by researchers at UT Southwestern Medical Center reveals significant disparities across the country in the use of immunotherapy for patients with advanced kidney and bladder cancers. The findings, published in ...
Sep 4, 2024
1
0
Immune checkpoint inhibitors are a type of cancer treatment that helps the immune system attack cancer cells more effectively. One of the key proteins involved in this process is lymphocyte activation gene-3 (LAG3), which ...
Sep 4, 2024
0
0
The American Journal of Gastroenterology has published a new guideline on the treatment of Helicobacter pylori (H. pylori) infection.
Sep 4, 2024
0
1
A treatment paradox has recently come to light in prostate cancer: Blocking testosterone production halts tumor growth in early disease, while elevating the hormone can delay disease progression in patients whose disease ...
Sep 4, 2024
0
73
New research led by Hanieh Yaghootkar, Senior Lecturer in Precision Health at the University of Lincoln, U.K., challenges the belief that liver fat is an independent risk factor for cardiovascular disease.
Sep 4, 2024
0
0
CDK4/6 inhibitors, which are already FDA approved for the treatment of other forms of cancer, show early signs of promise in the treatment of a subtype of pediatric high-grade glioma, according to new research from Dana-Farber ...
Sep 4, 2024
0
0
Two recent scientific papers about optimal treatment of older patients with cancer not only improve clinical care but also demonstrate Wilmot Cancer Institute's international leadership in this growing field.
Sep 4, 2024
0
0
